NCT06337318 2026-04-15Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaNational Cancer Institute (NCI)Phase 3 Recruiting600 enrolled
NCT04799275 2026-04-14Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaNational Cancer Institute (NCI)Phase 2/3 Suspended422 enrolled